WHO Updates the Nomenclature of SARS-CoV-2 Variants
WHO Updates the Nomenclature of SARS-CoV-2 Variants
Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.
Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.
B.1.351
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
Lisa Winter | May 6, 2021 | 2 min read
Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021 | 3 min read
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
Another Potentially Immunity-Evading SARS-CoV-2 Variant Detected
Asher Jones | Feb 16, 2021 | 2 min read
B.1.525 shares a mutation with the B.1.351 variant first detected in South Africa that seems to allow the virus to dodge the immune system.
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
Abby Olena, PhD | Feb 16, 2021 | 4 min read
Researchers identify deletions in the N-terminal domain of the spike protein that allow the coronavirus to avoid antibody neutralization and that may contribute to the emergence of new variants.
Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021 | 3 min read
Here’s our brief guide to the most noteworthy mutations in the novel coronavirus.
A Guide to Emerging SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021 | 10 min read
Scientists across the world are closely tracking the spread of mutations in the coronavirus and investigating whether they could render current vaccines less effective.
Moderna Developing Booster Shot for New Virus Variant B.1.351
Asher Jones | Jan 25, 2021 | 2 min read
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.